Treatment journey of patients with hepatocellular carcinoma using real-world data in British Columbia, Canada.
| Autor: | Seung SJ; Sunnybrook Research Institute, HOPE Research Centre, Toronto, Canada., Saherawala H; Sunnybrook Research Institute, HOPE Research Centre, Toronto, Canada., Zagorski B; BMZ Analytics, Toronto, Canada., Tong C; Provincial Health Services Association, Vancouver, Canada., Lim H; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada., Kim P; Department of Surgery, University of British Columbia, Vancouver, Canada., Marquez V; Division of Gastroenterology, Vancouver General Hospital, Vancouver, Canada., Gill S; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada., Liu D; Department of Radiology, Vancouver General Hospital, Vancouver, Canada., Davies JM; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Hepatic oncology [Hepat Oncol] 2024 Mar 14; Vol. 10 (4), pp. HEP50. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2023). |
| DOI: | 10.2217/hep-2023-0004 |
| Abstrakt: | Aim: This study examined treatment patterns, survival outcomes and healthcare costs related to hepatocellular carcinoma (HCC) in British Columbia. Methods: The study utilized data from two physician databases (HCC and MOTION) and the provincial British Columbia transplant database. Results: The analysis revealed diverse treatment approaches and identified the varying treatment journeys of patients. Liver transplant and systemic therapies demonstrated improved survival rates. However, there was a scarcity of Canadian-specific cost data. Conclusion: The research emphasizes the complexities of managing HCC and underscores the need for personalized treatment strategies to enhance patient outcomes. These findings contribute valuable insights into HCC management and provide a foundation for future studies and interventions aimed at optimizing care and resource allocation. Competing Interests: Competing interests disclosure The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. (© 2024 The Authors.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|